MedTrace Logo

Validity and Reliability of the Turkish Version of HAnDE

NCT06536595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2024-08-09

No results posted yet for this study

Summary

The aim of the present study was to translate and cross-culturally adapt The Hand Scleroderma Experienced Experience (HAnDE) Scale into the Turkish language and investigate its reliability and validity in Turkish-speaking patients with systemic sclerosis.

Conditions

  • Scleroderma
  • Hand Rheumatism

Interventions

OTHER

Scales

Participants were asked to complete the HAnDE-T, MHISS, SF-36 and HAQ when they first came. After 1 week, they were asked to complete HAnDE-T for re-test.

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Deran Oskay, Prof. Dr. · Gazi University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-06-01
Completion
2024-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06536595 on ClinicalTrials.gov